Health technology company Philips is suspending the manufacture of some defibrillators in the United States and will make others under heightened scrutiny following criticisms from U.S. regulators, in a move it said would dent profits.
The Dutch company said on Wednesday it expected a hit of 20 million euros (US$24 million) to earnings before interest, taxes and amortization (EBITA) in the fourth quarter of 2017, and a 60 million euro impact for the whole of 2018.
The company made 2.2 billion euros of EBITA in 2016.
"Philips defibrillators currently in use by customers are recommended by Philips to remain in use, and should not be taken out of service as Philips has no reason to believe they pose a risk to patients," it said.
The U.S. Food and Drug and Administration (FDA) has been raising concerns about defibrillators, which use an electric shock to restore a malfunctioning heart's rhythm, since at least 2013.
Philips disclosed details of the current dispute in January, which focuses on "compliance with good manufacturing practice requirements" in and before 2015 at its facilities in Andover, Massachusetts, and in Bothell, Washington.
Despite the modest reduction in forecast earnings, the latest announcement may unnerve investors. Philips issued a similar warning in 2014 about FDA concerns over how it made medical scanners at its factories in Cleveland, Ohio.
That eventually led to further profit warnings and two years of production delays.
CEO Frans van Houten said the current situation was "quite different" because Philips had invested in quality control in recent years.
The scanner problems in Cleveland forced product redesigns and changes to the company's supply chain - neither of which were relevant in the current case, Van Houten said. He said FDA concerns centered on the company being able to document that products had been manufactured correctly.
"We have made tremendous progress since 2015 but that didn't matter," he said. "This is a consequence of past sins."
At 0720 GMT, Philips shares were down 0.2 percent at 35.01 euros.
Van Houten said the impact on earnings would be "limited", as Philips' global defibrillator sales amount to about 300 million euros a year, compared with group sales in 2016 of 24.5 billion euros.
The company said affected product lines had 2016 sales of around 140 million euros.
In March, the FDA ordered the recall of 47,000 Philips defibrillators manufactured between 2004 and late 2016.
The company will continue making some defibrillator lines, as well as parts, to ensure the products remain publicly available. It will also resume exports of defibrillators from the affected plants "once certain requirements have been met".
Van Houten said manufacturing of the suspended product lines would resume "in the course of 2018," likely in the third quarter.
Reuters
Wed Oct 11 2017
Following criticisms from U.S. regulators, Philips is suspending the manufacture of some defibrillators in the U.S. and will make others under heightened scrutiny.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
Berita tempatan pilihan sepanjang hari ini
Berikut adalah berita yang paling menjadi tumpuan sepanjang Selasa, 17 September 2024.
Warga emas maut dihempap pokok
Seorang lelaki warga emas maut manakala cucunya cedera apabila dihempap pokok tumbang ketika sedang berkhemah.
Tumpuan Rabu – 18 September 2024
Ikuti rangkuman berita utama yang menjadi tumpuan di Astro AWANI.
Belanjawan 2025: Kerajaan fokus strategi stabilkan inflasi - Fadillah
Kerajaan Persekutuan akan memfokus kepada beberapa strategi dalam menstabilkan inflasi sekali gus menangani cabaran kenaikan kos sara hidup rakyat dalam Belanjawan 2025.
Ketua Menteri Delhi Kejriwal letak jawatan, pembantu utama sebagai pengganti
Ketua menteri Delhi, Arvind Kejriwal, meletak jawatan pada Selasa dan digantikan oleh pembantu utamanya Atishi Marlena.
AWANI 7:45 [17/09/2024] - Definasi halal semakin berkembang | Tiada sejarah ke luar negara | Ibu bapa sudah dikenal pasti | Jumlah mangsa meningkat
#AWANI745 malam ini bersama Essan Yahya;
1. Sijl halal bukan lagi soal babi dan alkohol, kata PM
2. Kes terbaharu mpox di Malaysia
3. 392 kanak-kanak jadi mangsa GISBH, ada ibu bapa enggan akui anak
4. Banjir di Kedah dan Pulau Pinang semakin memburuk
1. Sijl halal bukan lagi soal babi dan alkohol, kata PM
2. Kes terbaharu mpox di Malaysia
3. 392 kanak-kanak jadi mangsa GISBH, ada ibu bapa enggan akui anak
4. Banjir di Kedah dan Pulau Pinang semakin memburuk
AWANI Ringkas: Tujuh PPS dibuka di Pulau Pinang
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
LLB beri amaran jangan hampiri pantai, R&R Bagan Ajam
Gabungan air pasang besar berserta hujan lebat dan ribut menyebabkan fenomena ombak besar yang menghempas kawasan tepi laut Pulau Pinang terutama di sekitar Pantai Bersih.
Banjir di Kedah semakin memburuk, bilangan mangsa cecah 1,018 orang
Situasi banjir di Kedah makin memburuk selepas bilangan mangsa mencecah 1,018 orang daripada 268 keluarga yang ditempatkan di 11 pusat pemindahan sementara (PPS) di negeri ini.